Bone fragility in a post-intestinal transplant patient with mesenteric heterotopic ossification
Abstract
Heterotopic ossification (HO) is the aberrant formation of mature lamellar bone in extraskeletal tissues, most commonly following trauma or surgery. Mesenteric involvement is rare and often discovered incidentally. We report the case of a 44-yr-old man with mesenteric HO in the setting of multiple emergent abdominal surgeries after a motor vehicle accident. Histopathology confirmed bone with cartilage and BM within the mesentery. He subsequently required an isolated small-intestinal transplantation for short gut syndrome. Following transplantation, the patient developed multiple vertebral compression fractures in the setting of bone fragility due to chronic antirejection medications and high-dose steroid use. He received more than a decade of treatment with zoledronic acid, with stabilization of BMD and no additional fractures. He was later transitioned to denosumab. This case underscores the rarity of HO occurring in the mesentery and highlights the challenges of managing bone fragility in high-risk post-intestinal transplant patients. This case highlights the importance of monitoring and managing bone fragility in patients undergoing intestinal transplantation and long-term immunosuppressive therapy.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Irisin Enhances Osteoblast DifferentiationIn Vitro
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- Interaction between Schwann Cells and Osteoblasts In Vitro
- Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro
- The Effect of the Major Components of Fructus Cnidii on Osteoblasts In Vitro
- Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.